The Food & Drug Administration's recent approval of process analytical technology (PAT) for use in the pharmaceutical industry is being hailed by drug manufacturers because it encourages process ...

Improving product quality and lowering costs are the key factors behind the decisions made in many industries. Ensuring product quality throughout the manufacturing process can be time-consuming, with ...

In the context of current good manufacturing practice (cGMP), a number of pharmaceutical manufacturers are incorporating Process Analytical Technologies (PAT), Quality by Design (QbD), or Process ...

Cell therapy developers need purpose-built process monitoring technologies, according to researchers who say better systems would accelerate manufacturing and reduce costs. The conclusion is based on ...

Expansive growth in the gene and cell therapy (GCT) space has led to developers and manufacturers facing a multitude of challenges on the road to commercialization. To overcome issues associated with ...

Process analytical technology (PAT) describes the FDA-endorsed framework for measuring and controlling pharmaceutical manufacturing processes through real-time data collection and analysis. The FDA's ...

As part of current good manufacturing practice (cGMP), many pharmaceutical manufacturers are adopting Process Analytical Technologies (PAT), Quality by Design (QbD), or Process Validation (PV) to ...

The combination of scanning electron microscopy (SEM) images and energy-dispersive X-ray spectroscopy (EDS) maps (SEM–EDS analysis) enables the analysis of the relationship between the microstructures ...

Business process analysis (BPA) is a methodology that helps organizations deeply examine internal processes to find opportunities for improvement. BPA helps to identify processes that can be made more ...